These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 28836307

  • 21. PLP1 gene mutations cause spastic paraplegia type 2 in three families.
    Yao L, Zhu Z, Zhang C, Tian W, Cao L.
    Ann Clin Transl Neurol; 2023 Mar; 10(3):328-338. PubMed ID: 36622199
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Mutations in the PLP1 gene residue p. Gly198 as the molecular basis of Pelizeaus-Merzbacher phenotype.
    Hoffman-Zacharska D, Kmieć T, Poznański J, Jurek M, Bal J.
    Brain Dev; 2013 Oct; 35(9):877-80. PubMed ID: 23245814
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. PLP overexpression perturbs myelin protein composition and myelination in a mouse model of Pelizaeus-Merzbacher disease.
    Karim SA, Barrie JA, McCulloch MC, Montague P, Edgar JM, Kirkham D, Anderson TJ, Nave KA, Griffiths IR, McLaughlin M.
    Glia; 2007 Mar; 55(4):341-51. PubMed ID: 17133418
    [Abstract] [Full Text] [Related]

  • 29. PLP1 splicing abnormalities identified in Pelizaeus-Merzbacher disease and SPG2 fibroblasts are associated with different types of mutations.
    Bonnet-Dupeyron MN, Combes P, Santander P, Cailloux F, Boespflug-Tanguy O, Vaurs-Barrière C.
    Hum Mutat; 2008 Aug; 29(8):1028-36. PubMed ID: 18470932
    [Abstract] [Full Text] [Related]

  • 30. Genetic background influences UPR but not PLP processing in the rumpshaker model of PMD/SPG2.
    McLaughlin M, Karim SA, Montague P, Barrie JA, Kirkham D, Griffiths IR, Edgar JM.
    Neurochem Res; 2007 Feb; 32(2):167-76. PubMed ID: 16944321
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Olig2-lineage cells preferentially differentiate into oligodendrocytes but their processes degenerate at the chronic demyelinating stage of proteolipid protein-overexpressing mouse.
    Shimizu T, Tanaka KF, Takebayashi H, Higashi M, Wisesmith W, Ono K, Hitoshi S, Ikenaka K.
    J Neurosci Res; 2013 Feb; 91(2):178-86. PubMed ID: 23172790
    [Abstract] [Full Text] [Related]

  • 34. A case of complicated spastic paraplegia 2 due to a point mutation in the proteolipid protein 1 gene.
    Lee ES, Moon HK, Park YH, Garbern J, Hobson GM.
    J Neurol Sci; 2004 Sep 15; 224(1-2):83-7. PubMed ID: 15450775
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Novel exon 3B proteolipid protein gene mutation causing late-onset spastic paraplegia type 2 with variable penetrance in female family members.
    Sivakumar K, Sambuughin N, Selenge B, Nagle JW, Baasanjav D, Hudson LD, Goldfarb LG.
    Ann Neurol; 1999 May 15; 45(5):680-3. PubMed ID: 10319897
    [Abstract] [Full Text] [Related]

  • 37. Current concepts of PLP and its role in the nervous system.
    Griffiths I, Klugmann M, Anderson T, Thomson C, Vouyiouklis D, Nave KA.
    Microsc Res Tech; 1998 Jun 01; 41(5):344-58. PubMed ID: 9672418
    [Abstract] [Full Text] [Related]

  • 38. Teriflunomide attenuates neuroinflammation-related neural damage in mice carrying human PLP1 mutations.
    Groh J, Hörner M, Martini R.
    J Neuroinflammation; 2018 Jul 03; 15(1):194. PubMed ID: 29970109
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.